Problems of the segment of medicines for children in pharmacy organizations

In the daily clinical practice of a pediatrician, in order to increase the efficiency and safety of pharmacotherapy, the use of drugs should take into account and study the individual characteristics of the child's body and in accordance with the requirements of typical clinical and pharmacological characteristics. There is a problem with the production of drugs for low birth weight infants, as well as a problem of prescribing drugs, which have not been sufficiently investigated. There is very little data on the safety of medicine use in children and insufficient specific pediatric formulations. Objective: to study the problems of the segment of medicines for children in pharmacy organizations. Material and methods. The investigators used a set of methods: system analysis, marketing analysis of assortments, sociological survey. Results. At the moment, it is necessary to note a lack of knowledge regarding the characteristics of pediatric medicines, their relationship to the physiology of a child, and regarding adequate doses and formulations, etc. There are a number of restrictions on the manufacture of prescription drugs for children in pharmacies. The Russian industry practically does not produce children's dosage forms, whereas drugs made in foreign countries are not registered in the Russian Federation. Conclusion. The priority tasks in improving the manufacture of pediatric formulations are to conduct adequate clinical trials of drugs with the participation of children and to design special dosage forms for use in pediatrics, which will be able to register effective and safe drugs in the pediatric population in the future.

pediatrics, pharmacotherapy, medicines, pharmacy organization, clinical trials